WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameWuXi AppTec Co., Ltd.
-
Registration countryChina
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









